Abstract:You have accessJournal of UrologyBenign Prostatic Hyperplasia: Basic Research & Pathophysiology1 Apr 2018MP45-10 BLEBBISTATIN MODULATES PROSTATIC CELL GROWTH AND CONTRACTILITY THROUGH MYOSIN II SIGNALING Ping Chen, Deqiang Xu, He Xiao, Xinghuan Wang, Michael E DiSanto, and Xinhua Zhang Ping ChenPing Chen More articles by this author , Deqiang XuDeqiang Xu More articles by this author , He XiaoHe Xiao More articles by this author , Xinghuan WangXinghuan Wang More articles by this author , Michael E DiSantoMichael E DiSanto More articles by this author , and Xinhua ZhangXinhua Zhang More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.1449AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Benign prostatic hyperplasia (BPH) is mainly caused by increased prostatic volume and smooth muscle (SM) tone. Non-muscle myosin II (NMM II) and SM myosin II (SMM II) play important roles in mediating cell growth and SM tone. Blebbistatin (BLEB, a small, cell permeable molecule which inhibits NMM II) has been recently suggested to inhibit SM contraction. The aim of this study is to investigate the effect of blebbistatin on regulating contractility and growth of prostate cells and to provide insight into possible mechanisms associated with these actions. METHODS BPH-1 (human epithelia cell line) and WPMY-1 (human stroma cell line) cells were utilized for in vitro studies. For in vivo studies, 2-weeks of BLEB treatment was administered by direct injection to the rat prostate. Cell growth was determined by flow cytometry analysis and in vitro organ bath studies were performed to explore contractility of rat prostate. SMM isoforms, including SM myosin heavy chain (MHC) isoforms (SM1/2 and SM-A/B) and myosin light chain 17 isoforms (LC17a/b), isoform ratios were determined via competitive RT-PCR. SM MHC, NM MHC isoforms (NMMHC-A and NMMHC-B) and proteins related to cell apoptosis and cell cycle were further analyzed via Western blotting and Masson's trichrome staining was used to determine epithelium, SM and collagen content. RESULTS In vitro experiments displayed that BLEB could dose-dependently trigger apoptosis and retard the growth of BPH-1 and WPMY-1. Consistent with this in vitro effect, administration of BLEB to the prostate could decrease rat prostatic epithelia and SM cells via increased apoptosis. Western blotting confirmed the effects of BLEB on inducing apoptosis through a mechanism involving MLC20 dephosphorylation with downregulation of Bcl-2 and upregulation of BAX and cleaved caspase 3. Meanwhile, NMMHC-A and NMMHC-B, the downstream proteins of MLC20, were found significantly attenuated in BPH-1 and WPMY-1 cells, as well as rat prostate tissues. In addition, in vivo experiments also demonstrated that BLEB not only decreased SM cells and SM MHC expression, but also lessened phenylephrine (PE) induced contractile force and altered prostate SMM II isoform composition, with upregulation of SM-B and downregulation of LC17a, favoring a faster contraction. CONCLUSIONS Our novel data demonstrated that BLEB regulates myosin II expression and functional activity in vivo and in vitro. Thus, our study indicated that BLEB not only decreased prostate size (static component) but also changed the prostatic SM tone (dynamic component). © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e601 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Ping Chen More articles by this author Deqiang Xu More articles by this author He Xiao More articles by this author Xinghuan Wang More articles by this author Michael E DiSanto More articles by this author Xinhua Zhang More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Blebbistatin modulates prostatic cell growth and contrapctility through myosin II signaling.

MP45-10 BLEBBISTATIN MODULATES PROSTATIC CELL GROWTH AND CONTRACTILITY THROUGH MYOSIN II SIGNALING

Blebbistain, A Myosin Ii Inhibitor, As A Novel Strategy To Regulate Detrusor Contractility In A Rat Model Of Partial Bladder Outlet Obstruction

In Vitro And In Vivo Relaxation Of Corpus Cavernosum Smooth Muscle By The Selective Myosin Ii Inhibitor, Blebbistatin

In vitro and in vivo relaxation of urinary bladder smooth muscle by the selective myosin II inhibitor, blebbistatin.

Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates

Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia

Blebbistatin Inhibits the Chemotaxis of Vascular Smooth Muscle Cells by Disrupting the Myosin Ii-Actin Interaction

Testosterone Regulates Myosin II Isoforms Expression and Functional Activity in the Rat Prostate.

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate

Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate

Inhibition of LIM Kinase Reduces Contraction and Proliferation in Bladder Smooth Muscle

Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease

Modulation of the Differentiation Status of Cultured Prostatic Smooth Muscle Cells by an ?1-Adrenergic Receptor Antagonist

Testosterone Regulates Smooth Muscle Contractile Pathways in the Rat Prostate: Emphasis on PDE5 Signaling.

MP17-19 THE EXPRESSION AND FUNCTIONAL ACTIVITIES OF SMOOTH MUSCLE MYOSIN AND NON-MUSCLE MYOSIN ISOFORMS IN RAT PROSTATE

Acetylbritannilactone Inhibits Smooth Muscle Cell Proliferation Through Suppression of Cell Cycle Progression, ERK1/2 Activation, and Induction of Apoptosis

Inhibition of Human Prostate Smooth Muscle Contraction by the Inhibitors of Protein Kinase C, GF109203X, and Go6983

17β-Estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins

Blebbistatin Inhibits Sphingosylphosphorylcholine-Induced Contraction of Collagen-Gel Fiber Populated by Vascular Smooth-Muscle Cells.

17beta-estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins.